Health
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity – MENAFN.COM
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell ImmunityVancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology…
(MENAFN – Newsfile Corp) BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity
Vancouver, British Columbia–(Newsfile Corp. – November 2, 2020) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine research and development, announced today that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE related…
-
Noosa News23 hours agoQueensland teachers strike for second time this year after rejecting 8 per cent wage rise
-
General23 hours agoVictorian government blocked fire service from pursuing US giant over PFAS contamination
-
Noosa News14 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
General15 hours agoLabor to squeeze public service, sparking warnings of job losses